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Background: Traditional descriptions of infective endocarditis (IE) are still largely based on data obtained several decades ago, when patients 
presented and diagnosed with more advanced disease and therefore more classic symptoms and signs could be found.The purpose of this study was 
to understand the clinical manifestation, and laboratory findings of patients with IE in the 21st century.
Methods: Retrospective case-control study patients admitted with possible diagnosis of IE. The baseline cohort comprised of adult patients 
referred for echocardiography with a primary indication to investigate possibility of IE between Jan 2005 to 2010. Cases were defined as patients 
who met Modified Duke Criteria for IE and the rest of the cohort were defined as control group. The health records were examined for demographic 
data, symptoms, risk factors, physical exam finding and Laboratory test results, and outcome.
Results: 44 patients were diagnosed with IE and the rest (36) were assigned as control group. Both groups were similar in baseline characteristics. 
Mean age was 47 and 51 in case and control groups respectively. 50% and 41 % of case and control group were using IV illicit drugs. Most 
classic signs of IE including Janeway lesion (5 vs 2), and Osler’s node (3 vs 1), and Roth spot (2 vs 0) were not common and not significantly 
different between the groups. Of physical exam findings, tachycardia at presentation (24 vs 6, p= 0.0004), elevated JVP (11 vs 2, p=0.03) and 
splinter hemorrhage (6 vs 0 p=0.04) were significantly more common in IE group. More patients in IE group had anemia (31 vs 16 p=0.02), 
thrombocytopenia (14 vs 4 p=0.03), hematuria and proteinuria. Of these findings only tachycardia, hematuria, and anemia remained significantly 
more common in multivariate analysis. Mortality was 20% (9).
Conclusion: In the new era, patients with IE present with more non-specific symptoms and most classical signs of IE were not different between 
the case and control group. Also in a cohort of patients in whom clinician’s suspicion for IE is high, presence of tachycardia, and markers of chronic 
infection ie. anemia and hematuria might increase the odds of having infective endocarditis.
